Overview Financials News + Filings Key Docs Charts Ownership Insiders |
AmeriCann, Inc. (ACAN)
|
Add to portfolio |
|
|
Price: |
$0.55
| | Metrics |
OS: |
24.4
|
M
| |
4
|
% ROE
|
Market cap: |
$13.4
|
M
| |
7
|
% ROIC
|
Net debt:
|
$3.09
|
M
| |
2.2
|
x Debt/EBITDA
|
EV:
|
$16.5
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$1.4
|
M
| |
11.8
|
x EV/EBITDA
|
EBIT
|
$945.6
|
k
| |
17.4
|
x EV/EBIT
|
EPS |
$0.01
| |
59.1
|
x P/E
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
Revenues | 2.9 | 2.0 | 0.5 | 0.0 | 2.0 | 0.0 | 0.1 | 0.1 |
Revenue growth | 44.3% | 302.9% | 4254.1% | -99.4% | 4973.6% | -33.3% | -57.1% | 366.7% |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 3.4 | 2.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 2.9 | 2.0 | 0.5 | -3.4 | 0.0 | 0.0 | 0.1 | 0.1 |
Gross margin | 98.4% | 98.1% | 95.5% | -29332.8% | 0.0% | 100.0% | 100.0% | 100.0% |
Selling, general and administrative | | | | | | | | |
Sales and marketing | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
General and administrative | 2.4 | 1.9 | 2.4 | 2.5 | 2.0 | 1.8 | 1.2 | 0.8 |
EBIT | 0.5 | 0.0 | -0.2 | -3.4 | -2.0 | -1.8 | -1.1 | -1.8 |
EBIT margin | 16.5% | 2.2% | -37.1% | -29332.8% | -100.0% | -4495.5% | -1882.4% | -1291.0% |
Pre-tax income | -0.2 | -0.9 | -0.7 | -4.9 | -4.4 | -2.8 | -2.2 | -1.7 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -0.2 | -0.9 | -0.7 | -4.9 | -4.4 | -2.8 | -2.2 | -1.7 |
Net margin | -5.9% | -42.5% | -140.9% | -42404.6% | -218.4% | -6929.7% | -3684.6% | -1235.2% |
|
Diluted EPS | ($0.01) | ($0.04) | ($0.03) | ($0.21) | ($0.22) | ($0.15) | ($0.13) | ($0.10) |
Shares outstanding (diluted) | 24.3 | 23.9 | 23.5 | 23.0 | 20.1 | 19.0 | 17.0 | 16.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|